Skip to main content
. 2021 Apr 2;12(11):3190–3197. doi: 10.7150/jca.54429

Figure 1.

Figure 1

FCM clustering analysis of 341 metabolites from normal participants to HGD/ESCC patients. LGD, low-grade dysplasia; HGD, high-grade dysplasia; ESCC, esophageal squamous cell carcinoma. Each of these lines represents a metabolite. The color of the line indicates the membership of the metabolite in cluster.